· 3/21/2000
Hollander v. Sandoz Pharmaceuticals Corp.
Citations
- 95 F. Supp. 2d 1230
- 2000 U.S. Dist. LEXIS 8776
- 2000 WL 430174
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- excluding Dr. Kulig’s testimony and stating that he “could only list ‘possible’ mechanisms for Parlodel® causing hypertension”
- rejecting Dr. Kulig’s reliance on case reports because, inter alia, these reports “fail to take into account the postpartum incidence of stroke and other factors”
- no reliable evidence that “bromocriptine and the other Ergots have sufficiently similar physiological effects to warrant comparison”
- “The plaintiffs have failed to demonstrate that bromocriptine and the other ergots have sufficiently similar physiological effects to warrant comparison.”
- “The plaintiffs have failed to demonstrate that bromocriptine and the other ergots have sufficiently similar physiological effects to warrant comparison.”
- rejecting Dr. Kulig’s reliance on other ergots evidence
Source: CourtListener parenthetical corpus (CC0).
Judges: Ralph G. Thompson
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.